Investor Presentaiton

Balance Sheet- Consolidated 2017/12/31 2016/12/31 (In NT$ million) (Unaudited) (Audited) Cash and Cash Equivalents 3,911 31% 3,707 29% Accounts Receivable 567 4% 638 5% Inventories 1,675 13% 1,830 14% Long-Term Investments 391 3% 364 3% Property, Plant & Equipment 5,089 40% 5,209 41% Other Current/Non-Current Assets 1,068 9% 1,035 8% Total Assets 12,701 100% 12,783 100% Current Liabilities 1,115 9% 1,692 13% Long-Term & Other Liabilities 1,169 9% 863 7% Total Liabilities 2,284 18% 2,555 20% Total Shareholders' Equities 10,417 82% 10,228 80% Key Indices A/R Turnover (Days) 65.6 71.6 Inventory Turnover (Days) 434.5 405.6 Current Ratio (x) 5.8 3.9 ROE (%) 4.1 6.6 21 24 ScinoPharm

View entire presentation